Study Information
Locations
Clinical Trial FAQs
Information for patients and study volunteers, including frequently asked questions.
Description
In the study, an extra blood sample is taken during regular blood tests when a pregnant woman is admitted to a Sutter Health hospital to give birth. These samples are stored in the Sutter Health biobank, and will be tested for COVID-19 antibodies.
The goal is to study the spread of COVID-19 in pregnancy and determine if infection rates differ by race, ethnicity, and other factors.
In addition to Alice Pressman, Ph.D., M.S, and Gregory Tranah, Ph.D., Stephen Lockhart, M.D., Ph.D., is also a principal investigator.
Eligibility Requirements
Any pregnant woman giving birth at a Sutter Health hospital.
Principal Investigator
Alice R. Pressman, Ph.D., M.S., Gregory J. Tranah, Ph.D.
Recruitment Information
Learn More About the Study. Complete the short form and someone from the study will call you back.
You can also reach the Quality and Health Equity Solutions study team at (800) 524-1440.
Funder
Sutter Health
Related Studies
Bay Area Breastfeeding Experience Survey (BABES)
Breast Tumor and Blood markers for Molecular Diagnosis of Breast Diseases and Monitoring of Breast Cancer Treatment and Follow-up
Improving Outcomes for Breast Cancer Patients: A PAMF-Stanford Research Collaboration
Investigators: Su-Ying Liang, Ph.D., Harold (Hal) Luft, Ph.D.
Latinas' Experiences of Breast Cancer Treatment in Santa Cruz County
Lung Cancer in Never Smokers: Incidence, Risk Factors and Molecular Characteristics in Asian American, Native Hawaiian, and Pacific Islander (AANHPI) Women
Investigators: Harold (Hal) Luft, Ph.D., Su-Ying Liang, Ph.D., External PI, Principal Investigator
Measuring Real-World Breast Cancer Care
Investigator: Sandra Wilson, Ph.D.
Primary and Secondary Prevention of Osteoporosis-Related Fracture: The Use of DEXA and FRAX Results in a Community–based Practice
Investigator: Harold (Hal) Luft, Ph.D.
Towards an Understanding of the Influence of Significant Others on Breast Cancer Patients’ Treatment Decision Making
Investigator: Harold (Hal) Luft, Ph.D.